Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives
Vivien C Abad Department of Psychiatry & Behavioral Sciences, Division of Sleep Medicine, Stanford University, Redwood City, CA 94063, USACorrespondence: Vivien C AbadDepartment of Psychiatry & Behavioral Sciences Division of Sleep Medicine, Stanford University Outpatient Center, 450...
Guardado en:
Autor principal: | Abad VC |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/629dd71a3da84861a4f3bfc25de85b27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Management Of Excessive Sleepiness In Patients With Narcolepsy And OSA: Current Challenges And Future Prospects
por: Sahni AS, et al.
Publicado: (2019) -
Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility
por: Guevarra JT, et al.
Publicado: (2020) -
Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients
por: Talih FR, et al.
Publicado: (2017) -
Occupational Outcomes Associated with Sleep Quality and Excessive Daytime Sleepiness: Results from a National Survey
por: AlShareef SM
Publicado: (2020) -
Narcolepsy Type 1: A Remitting Disease? An Unusual Case Report
por: Vellieux G, et al.
Publicado: (2021)